What Phoenix Labs does

Phoenix Labs Unlimited Company is an Irish specialty pharmaceutical company, incorporated in June 2000 and headquartered in Clonee, Co. Meath, Ireland. The company manufactures and distributes both prescription (Rx) pharmaceuticals — including branded and generic medications across pain management, oncology support, dermatology, cardiovascular, infectious disease and injectable categories (e.g., Famvir, Zometa, Warticon, Actiq, Effentora, Solpadol, Profenid) — and over-the-counter (OTC) consumer healthcare products spanning cold and flu remedies, cough syrups, oral rehydration therapy, baby care, analgesics, vitamins and skincare (e.g., Uniflu, Exputex, Dioralyte, Snufflebabe, Dentinox, Pharmony, Paralink, Astral, Dalivit). Operates two manufacturing sites in Tallaght (Dublin) and Watford (UK), acquired via the 2020 Dendron Brands and 2021 Phoenix Healthcare (Rice Steele) transactions.

Revenue is generated through unit sales of prescription and OTC products via a multi-channel distribution network: direct sales to general practitioners and hospitals, retail pharmacy channel, and international distribution across 22 countries spanning the UK, 18 additional European markets, Australia and New Zealand. Pricing is not publicly disclosed; the model is one-time sale per unit with no subscription, SaaS or licensing platform component. The company pursues an acquisition-led growth strategy, having absorbed three operating pharma businesses and at least one brand portfolio since 2010, with a stated focus on marketing established brands acquired from multinational pharmaceutical companies.

Name

Phoenix Labs

Legal name

Phoenix Labs

Website

https://phoenixlabs.ie

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

11–50 employees

Short description

Phoenix Labs is an Irish specialty pharmaceutical company founded in 2000 that manufactures and distributes prescription and OTC healthcare products across 22 countries, operating two manufacturing sites in Ireland and the UK and building its portfolio through acquisitions of established multinational pharma brands.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD)

akta.pro secondary industries

OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief) (CRADAMAC), Digestive Health OTC (Antacids, Laxatives, Anti-diarrheals, Probiotics OTC) (CRADAMAE), Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal) (CRADAMAF), Pain Relief & Anti-Inflammatory (Analgesics) (HLAIADAA)

Keywords

• Prescription pharmaceuticals
• Over-the-counter medicines
• Baby care products
• Cold and flu remedies
• Oral rehydration therapy

Headquarters

HQ city

Clonee

HQ country

Ireland

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. OTC Product Sales: Sale of over-the-counter healthcare products including cold/flu remedies, cough syrups, oral rehydration therapy, and baby care products through pharmacies and retail channels.
2. Prescription Product Sales: Sale of prescription pharmaceuticals including branded and generic medications across therapeutic areas including pain management, oncology, dermatology, and cardiovascular treatments.

Distribution channels3 records

Marketing channels1 record

Core offering

Phoenix Labs manufactures and distributes a portfolio of prescription (Rx) and over-the-counter (OTC) pharmaceutical products from manufacturing facilities in Ireland and the United Kingdom. The Rx portfolio includes branded and generic medications across pain management, oncology support, cardiovascular, dermatology, infectious disease, endocrinology, and gastrointestinal areas. The OTC portfolio includes oral rehydration products (Dioralyte), cough and cold remedies (Exputex, Uniflu), baby care (Snufflebabe, Dentinox, Pharmony), vitamins (Dalivit, Rubex), and topical products. Products are sold across approximately 22 countries in Europe, the UK, Australia, and New Zealand through pharmacies, healthcare professionals, hospitals, and international distributors.

Product overview

Phoenix Labs is an integrated healthcare company operating in both prescription (Rx) and over-the-counter (OTC) market segments across Ireland, UK, and Europe. The company offers a diverse portfolio of pharmaceutical and health/wellness products through multiple sub-brands. The OTC portfolio includes core brands such as Dioralyte (oral rehydration), Exputex (expectorant cough syrup), Uniflu (cold and flu treatment in multiple forms including with Vitamin C, CoughStop Syrup, and Throat Syrup for Kids), and acquired brands including Snufflebabe (baby decongestants), Pharmony (gripe water and throat syrup), Dentinox (baby care including colic drops, teething gel, and cradle cap treatments), and others like Bloateze, Casacol, Anthisan, Paralink, Dozol, Teedex, Rubex, Medijel, OroSoothe, Arthrimel, Astral, Cepton, and Dalivit vitamins. The prescription portfolio encompasses medications across therapeutic areas including pain management (Solpadol, Profenid), oncology support (Zometa, Actiq, Effentora), cardiovascular (Visken), dermatology (Dectancyl, DELTACORTRIL), infectious disease (FAMVIR), gastrointestinal (Glyvenol, PROCTOSEDYL), and various injectables and other pharmaceuticals. The company operates manufacturing sites in both the UK and Ireland.

Differentiator

Problem solved

Functional benefit

Brands

• Phoenix Healthcare: Pharmaceutical company with brands including Paralink, Rubex, Pharmony, Dozol & Teedex, formerly known as Rice Steele Ltd.
• Dendron Brands

Products and services

• Prescription Pharmaceuticals (Rx) Portfolio of branded and generic prescription medications across therapeutic areas including pain management, oncology support, cardiovascular, dermatology, infectious disease, endocrinology, gastrointestinal, rheumatology, migraine, ophthalmology, and anaesthesia; sold through GPs, hospitals and pharmacies.
• Dioralyte (Oral Rehydration Therapy) Market-leading OTC oral rehydration therapy containing electrolytes (glucose, sodium chloride, potassium chloride, disodium hydrogen citrate) for replacement of essential water and salt loss, particularly from diarrhoea; available in blackcurrant, citrus, and natural flavours in packs of 6s and 20s.
• Exputex (Cough Syrup) Leading brand of expectorant cough syrup in Ireland containing Carbocisteine and Menthol; sugar-free formula that liquefies mucous to clear phlegm from the chest.
• Uniflu with Vitamin C OTC cold and flu treatment containing 5 active ingredients (Paracetamol, Phenylephrine, Diphenhydramine, Caffeine, Vitamin C); available in packs of 12 and 24.
• Uniflu CoughStop Syrup OTC syrup with marshmallow root and honey flavour that calms dry cough and decreases irritation of the oral cavity and throat; suitable from 12 months; available in 100ml bottle.
• Uniflu Throat Syrup for Kids Sugar-free OTC throat syrup with natural ingredients and lemon and aniseed flavour for sore throats in children; suitable from 4 months+; available in 100ml bottle.
• Snufflebabe (Product Line) OTC baby decongestant range including Bath Bubbles, Nasal Aspirator, Room Vapour Oil, Nasal Drops, Nasal Spray, and Vapour Rub to help babies breathe, feed and sleep comfortably.
• Casacol Syrup OTC sugar-free expectorant and decongestant syrup liquefying tenacious mucous and facilitating easier breathing for cough and congestion associated with common cold and bronchitis; available in 125ml and 300ml.
• Dentinox (Product Line) OTC baby care line established for 60 years including Colic Drops, Cradle Cap Treatment Shampoo, Scalp Oil, and Teething Gel for relief from minor infant ailments.
• Pharmony (Product Line) OTC baby and child health line including Gripe Water (natural Dill and Caraway for wind and colic relief) and Throat Syrup with lemon oil; suitable from 4 months.
• Astral Original Intensive Moisturiser OTC intensive moisturiser tried and tested for over 60 years for skin care; available in 50ml, 200ml, and 500ml sizes.
• Cepton Medicated Skin Wash OTC daily acne treatment containing antiseptic chlorhexidine gluconate that removes oil and sebum and helps clear spots while providing a protective shield against bacterial infections.
• Dalivit Vitamin Drops OTC once-a-day multivitamin and Vitamin D3 drops for babies and toddlers, free from nuts; available in 25ml, 28ml and 50ml bottles.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered major.

• Phoenix Healthcare (formerly Rice Steele Ltd)majorStrategic or Co-development Partner · 1 January 2021Acquired Phoenix Healthcare (formerly Rice Steele Ltd) including company and manufacturing plant based in Tallaght, Dublin in 2021. Brands include Paralink, Rubex, Pharmony, Dozol & Teedex.
• Dendron Brands Ltd (formerly DDD Ltd)majorStrategic or Co-development Partner · 1 January 2020Acquired Dendron Brands Ltd, a company and manufacturing plant based in Watford, UK in 2020. Brands include Astral, Snufflebabe, Dentinox, Flourish, and Medijel.
• Uniphar PlcmajorOthers · 1 October 2010Acquired T.P. Whelehan & Co Ltd from Uniphar Plc in October 2010, expanding Phoenix Labs' presence in the Irish pharmaceutical market.

Scale indicators1 record

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Bayer Consumer Health: OTC division of Bayer covering pain, dermatology, allergy, and digestive health categories in which Phoenix Labs operates (Anthisan, Cepton, Bloateze, Dioralyte). A broader incumbent competitor across European pharmacy channels.
• Viatris Inc. Global pharmaceutical company formed from Mylan/Upjohn combining generics and a branded portfolio. Competes head-to-head with Phoenix Labs on off-patent Rx products and increasingly in OTC across European markets.
• Haleon plc: World-leading consumer healthcare company carved out of GSK with major OTC brands across cold/flu, pain relief, and oral health. Comparable to Phoenix Labs' OTC product categories but at vastly greater scale and global reach.
• Teva Pharmaceutical Industries: Global leader in generic pharmaceuticals with a meaningful OTC and specialty business. Operates many of the same off-patent molecules (e.g., famciclovir, paracetamol-codeine combinations) that sit in Phoenix Labs' Rx portfolio, and competes in Europe on supply and pricing.

Emerging players

• Aspen Pharmacare Holdings: South African-headquartered global generics and consumer healthcare group built heavily through acquisition of mature brands from multinational pharma. Compares closely to Phoenix Labs' strategy of buying and operating legacy brands at regional/specialty scale.
• Almirall S.A. Spanish mid-cap pharmaceutical company focused on dermatology and specialty Rx, with selected OTC products. Comparable regional mid-size European pharma footprint with branded portfolio strategy in dermatology (overlapping Phoenix Labs' Cepton, Astral, Anthisan).

Direct peers

• Perrigo Company plc: US/EU-listed OTC consumer healthcare company focused on store-brand and branded self-care products. Highly comparable to Phoenix Labs' model of operating mature, off-patent OTC/consumer health brands across multiple geographies with in-house manufacturing.
• STADA Arzneimittel AG: German-headquartered European generics and consumer healthcare company with a mature-brand acquisition playbook and presence across Europe. Closely mirrors Phoenix Labs' strategy of buying legacy pharma brands from multinationals and scaling them via pan-European distribution.
• Recordati S.p.A. Italian specialty and consumer healthcare pharmaceutical group with a portfolio of acquired and licensed brands across Europe. Similar mid-sized European pharma model with own manufacturing and presence in the same OTC and Rx subcategories.
• Zentiva Group: Pan-European generics and consumer healthcare company headquartered in Prague, serving many of the same Central European markets (Czech Republic, Slovakia, Hungary) that Phoenix Labs distributes into. Comparable OTC + Rx European playbook.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/phoenixlabs_
• LinkedInlinkedin.com/company/phoenix-labs-

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Phoenix Labs